The price of Revolution Medicines Inc (NASDAQ: RVMD) closed at $31.91 in the last session, up 2.05% from day before closing price of $31.27. In other words, the price has increased by $+0.64 from its previous closing price. On the day, 862684 shares were traded.
Ratios:
We take a closer look at RVMD’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 13.06 and its Current Ratio is at 13.06. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.04.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Piper Sandler on March 11, 2024, initiated with a Overweight rating and assigned the stock a target price of $43.
On January 05, 2024, BofA Securities Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $31 to $34.
On January 04, 2024, Wedbush started tracking the stock assigning a Outperform rating and target price of $41.Wedbush initiated its Outperform rating on January 04, 2024, with a $41 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 27 ’24 when Cislini Jeff sold 1,500 shares for $30.99 per share. The transaction valued at 46,481 led to the insider holds 54,374 shares of the business.
GOLDSMITH MARK A sold 5,788 shares of RVMD for $182,804 on Mar 18 ’24. The insider now owns 460,379 shares after completing the transaction at $31.58 per share. On Mar 18 ’24, another insider, Horn Margaret A, who serves as the Chief Operating Officer of the company, sold 2,914 shares for $31.58 each. As a result, the insider received 92,033 and left with 139,553 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RVMD now has a Market Capitalization of 5.26B and an Enterprise Value of 3.49B. For the stock, the TTM Price-to-Sale (P/S) ratio is 453.82 while its Price-to-Book (P/B) ratio in mrq is 2.88. Its current Enterprise Value per Revenue stands at 301.55 whereas that against EBITDA is -8.12.
Stock Price History:
Over the past 52 weeks, RVMD has reached a high of $35.60, while it has fallen to a 52-week low of $15.44. The 50-Day Moving Average of the stock is 30.42, while the 200-Day Moving Average is calculated to be 27.79.
Shares Statistics:
According to the various share statistics, RVMD traded on average about 1.35M shares per day over the past 3-months and 928.71k shares per day over the past 10 days. A total of 164.67M shares are outstanding, with a floating share count of 136.33M. Insiders hold about 17.22% of the company’s shares, while institutions hold 79.18% stake in the company. Shares short for RVMD as of Mar 15, 2024 were 16.4M with a Short Ratio of 12.13, compared to 16.96M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 9.96% and a Short% of Float of 10.34%.
Earnings Estimates
The company has 10 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.74 for the current quarter, with a high estimate of -$0.67 and a low estimate of -$0.85, while EPS last year was -$0.72. The consensus estimate for the next quarter is -$0.77, with high estimates of -$0.7 and low estimates of -$0.86.
Analysts are recommending an EPS of between -$2.99 and -$3.53 for the fiscal current year, implying an average EPS of -$3.18. EPS for the following year is -$3.47, with 10 analysts recommending between -$2.85 and -$4.02.
